Rocuronium – A Review

Abstract

ABSTRACT
Neuromuscular blockers (NMB) is an essential part of the anesthetist armamentarium. Intubation is a medical procedure involving the insertion of a tube into the body. Patients are generally anesthetized beforehand. They ally endotracheal intubations, mechanical ventilation, decrease anesthetic requirement, prevent patient movement, facilitate surgery, and decrease oxygen consumption. Changes in the direction of drug development have occurred as a result of the ingenuity of pharmaceutical chemist to face clinical needs. Rocuronium bromide (Esmeron) is a novel aminosteroidal nondepolarizing NMB introduced to the clinical use.

Keywords: blockers, clinical, intubation, neuromuscular, rocuronium
REFERENCES
[1] L.P. Yang, S.J. Keam. Sugammadex: a review of its use in anaesthetic practice, Drugs. 2009; 69(7): 919–42p.
[2] R. Soto, J.S. Jahr, J. Pavlin, et al. Safety and efficacy of rocuronium with sugammadex reversal versus succinylcholine in outpatient surgery – a multicenter, randomized, safety assessor-blinded trial, Am J Ther. 2015.
[3] M.K. Sorensen, C. Bretlau, M.R. Gatke, A.M. Sorensen, L.S. Rasmussen. Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine: a randomized trial, Br J Anaesth. 2012; 108(4): 682–9p.
[4] S.M. Siddik-Sayyid, S.K. Taha, G.E. Kanazi, J.M. Chehade, R.A. Zbeidy, A.A. Al Alami, B.W. Zahreddine, M.F. Khatib, A.S. Baraka, M.T. Aouad. Excellent intubating conditions with remifentanil-propofol and either lowdose rocuronium or succinylcholine, Can J Anaesth. 2009; 56: 483–8p.
[5] D.L. Reich, J. Mulier, J. Viby-Mogensen. Comparison of the cardio-vascular effects of cisatracurium and atracurium in patients with coronary artery disease, Can J Anesth. 1998; 45: 794p.
[6] Y.A. Ruetsch, A. Borgeat, Y.O. Chevchenko. Withdrawal movements associated with the injection of rocuronium, Anesth Analg. 2000; 90: 227p.
[7] D.W. Lowry, R.K. Mirakhur, G.J. McCarthy. Neuromuscular effects of rocuronium during sevoflurane, isoflurane and intravenous anesthesia, Anesth Analg. 1998; 87: 936p.
[8] J.H. Levy, G.K. Davis, J. Duggan, et al. Determination of the hemodynamic and histamine release of rocuronium (ORG 9426) when administered in increased doses under N2O-O2-suf-entanil anesthesia, Anesth Analg. 1994; 78: 318p.
[9] N. Gulhas, S. Topal, G.E. Kayhan, A. Yucel, Z. Begec, S. Yologlu, M. Durmus, M.O. Ersoy. Remifentanil without muscle relaxants for intubation in microlaryngoscopy: a double blind randomised clinical trial, Eur Rev Med Pharmacol Sci. 2013; 17: 1967–73p.
[10] T. Fuchs Buder, E. Tassonyi. Intubating conditions and time course of rocuronium – induced neuromuscular block in children, BJA. 1996: 77: 335–8p.
[11] M.A. Frakes. Muscle relaxant choices for rapid sequence induction, Air Med J. 2001; 20(1): 20–1p.
[12] B. Debaene, B. Plaud, M.P. Dilly, F. Donati. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action, Anesthesiology. 2003; 98: 1042–8p.
[13] J.Y. Dupuis, R. Martin, J.P. Tetrault. Atracurium and vecuronium interaction with gentamicin and tobramycin, Can J Anaesth. 1989; 36: 107–11p.
[14] T. Ezri, P. Szmuk, R.D. Warters, R.E. Gebhard, E.G. Pivalizza, J. Katz. Changes in onset time of rocuronium in patients pretreated with ephedrine and esmolol – the role of cardiac output, Acta Anaesthesiol Scand. 2003; 47: 1067–72p.
[15] C.A. Cheng, C.S. Aun, T. Gin. Comparison of rocuronium and suxamethonium for rapid tracheal intubation in children, Paediatr Anaesth. 2002; 12(2): 140–5p.
[16] W. Buzello, D. Schluermann, T. Pollmaecher, G. Spillner. Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium and vecuronium, Anesthesiology. 1987; 66: 842–6p.
[17] R. Cooper, R.K. Mirakhur, R.S.J. Clarke. Comparison of intubating condition after administration of ORG – 9426(Rocuronium) and suxamethonium, BJA. 1992; 69: 269–73p.
[18] S.L. Brull, G.S. Murphy. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness, Anesth Analg. 2010; 111: 129–40p.
[19] K. Barclay, K. Eggers, T. Asai. Low-dose rocuronium improves conditions for tracheal intubation after induction of anaesthesia with propofol and alfentanil, Br J Anaesth. 1997; 78: 92–4p.
[20] G. Ayano. Bipolar disorders and valproate: pharmacokinetics, pharmacodynamics and therapeutic effects and indications of valproate: review of articles, Bipolar Disord. 2016; 2: 109p.
[21] R.R. Bartkowski, T.A. Witkowski, S. Azad, J. Lessin, A. Marr. Rocuronium onset of action: a comparison with atracurium and vecuronium, Anesth Analg. 1993; 77: 574–8p.